Donatas Grabliauskas, General Manager, Johnson & Johnson Innovative Medicine Hong Kong & Macau (right). Building on more than five decades in Hong Kong, Johnson & Johnson is committed to advancing better health through science, innovation and collaboration for patients and communities in Hong Kong. The partnership will help strengthen clinical research, develop future healthcare talent and support Hong Kong's ambition to become a leading international health and medical innovation hub.